Literature DB >> 8678963

Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.

D Simon1, P E Goretzki, J Witte, H D Röher.   

Abstract

Total thyroidectomy has become the routine procedure for treatment of differentiated thyroid carcinoma. However, the necessity of unilateral or bilateral neck dissection is far less standardized. Our usual procedure has been to perform a routine neck dissection in T4 tumors and in all other tumor stages only in the presence of positive diagnostic or intraoperative findings. The results concerning regional tumor recurrence in cervical lymph nodes subsequent to thyroidectomy are studied and discussed. Between April 1986 and December 1992 a group of 252 patients were operated on for differentiated thyroid carcinoma (DTC) (176 papillary, 76 follicular). Postoperative treatment included radioiodine therapy as a rule in all patients more than stage T1, and follow-up encompassed thyroglobulin measurements, cervical ultrasonography, and radioiodine scintigraphy. After a mean follow-up of 6.9 years, 77 (31%) of the patients underwent reoperation because of regional tumor recurrence [46 of 176 (26%) papillary, 31 of 76 (41%) follicular]. In papillary thyroid cancer a significant difference could be demonstrated between patients with thyroidectomy only versus thyroidectomy plus neck dissection in all tumor stages (T2, 13 of 29 (45%) versus 1 of 34 (3%); T3, 10 of 13 (77%) versus 4 of 11 (36%); T4, 6 of 8 (75%) versus 6 of 18 (33%) (p < 0.0001). Similar results could be achieved for follicular thyroid cancer, showing statistical significance with regard to operative procedure (p < 0.009). Our experience demonstrates a positive correlation of regional tumor recurrence with increasing tumor stage for both histologic tumor types. The high rate of regional recurrence justifies a more radical approach, including neck dissection at the initial operation. The impact on survival, however, must be proved by further evaluation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678963     DOI: 10.1007/s002689900131

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  38 in total

Review 1.  The management of metastatic differentiated thyroid carcinoma.

Authors:  S I Sherman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.

Authors:  Amanda M Laird; Paul G Gauger; Barbra S Miller; Gerard M Doherty
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 3.  Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

4.  Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

Review 5.  Central lymph node dissection in differentiated thyroid cancer.

Authors:  Matthew L White; Paul G Gauger; Gerard M Doherty
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

6.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

7.  Morbidity of central neck dissection: primary surgery vs reoperation. Results of a case-control study.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Carmela De Crea; Luca Sessa; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

8.  Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma.

Authors:  Haitham Alfalah; Isaac Cranshaw; Thomas Jany; Laurent Arnalsteen; Emmanuelle Leteurtre; Catherine Cardot; François Pattou; Bruno Carnaille
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

9.  Thyroidectomy and lymph node dissection in papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2010-11-10

10.  Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.

Authors:  Iwao Sugitani; Yoshihide Fujimoto; Keiko Yamada; Noriko Yamamoto
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.